Login / Signup

Authors' Reply: Pharmacokinetic Issue May Influence the Perceived Cardiac Risk Posed by Ondansetron in Patients Undergoing Chronic Hemodialysis.

Sherine IsmailMichele Jonsson FunkJennifer E Flythe
Published in: Journal of the American Society of Nephrology : JASN (2024)
Keyphrases
  • patients undergoing
  • social support
  • depressive symptoms
  • peritoneal dialysis
  • chronic kidney disease
  • physical activity
  • mental health
  • left ventricular
  • end stage renal disease
  • heart failure